Leveraging advanced robotics, our tools provide comprehensive diagnostics and therapeutics for small intestinal diseases.
Small intestinal bleeding alone accounts for $220 million in US hospital costs annually.
Globally, the incidence of small intestinal bleeding is around 10 per 100,000 people, approx. 810,000 bleeds annually.
Patients typically require 12+ day stays in hospital and 4-6 procedures in order to manage bleeding due to limitations of current devices.
Introducing the EndoFlow Adapt
01
See Everything. Total enteroscopy in over 95% of cases, significantly improving diagnostic capabilities.
02
Simplify Scope Advancement. Efficiently shorten procedure times from 3 hours to under 45 minutes, allowing more patients to be treated.
03
Shorten Waits. Reduce hospital stays from 12 days to under 4 days by eliminating redundant steps in diagnosis.
Therapeutic Endoscopist,
St. Michael's Hospital
Assistant Professor, Division of Gastroenterology
University of Toronto
"Double balloon endoscopy is very slow paced. You spend hours trying to find the bleed, and then you can't get there. It's a frustrating space to be in."
Director of Advanced Therapeutic
Endoscopy Program,
Co-Director of Small Bowel Program,
University of Alberta
"Double balloon endoscopy is only good if it is used in the right hands, and very few people have the necessary training. A device that any endoscopist can use - that would be amazing!"
Committing to improve the quality of intestinal care through reliable therapies.
Tapping into the $36.9 billion global endoscopy market, which is expected to grow to $72 billion by 2032.
Utilizing advanced robotics to simplify small intestinal access and streamline procedures, reducing time and costs.
Expanding into the small intestinal market, with plans to secure 30% of the market by 2045.
Start improving patient outcomes with EndoFlow today. Get in touch with our experts for custom solutions to meet your healthcare facility's needs.
Version
© 2024 Flow Robotics. All rights reserved.
Socials